Camera vs. needle: study aims to speed up cancer diagnosis in lung fluid patients

NCT ID NCT06892691

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two ways to diagnose cancer in people with fluid buildup around the lungs (pleural effusion). One method, thoracentesis, drains the fluid with a needle. The other, pleuroscopy, uses a tiny camera to look inside and take tissue samples. Researchers want to see which approach gives a clear diagnosis faster and helps patients start cancer treatment sooner. About 98 adults with suspected cancer will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If this trial succeeds, it could show that pleuroscopy (a camera-guided biopsy) leads to faster cancer diagnosis and treatment than the standard fluid-drainage procedure.
What could go wrong
This is a small, early-stage study (98 people) comparing procedures, not testing a new drug. Results may not apply to all patients, and either procedure carries risks like infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm Pleural Effusion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mount Sinai Hospital

    RECRUITING

    New York, New York, 10029, United States

  • Mount Sinai West

    RECRUITING

    New York, New York, 10019, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.